Vifor Pharma

Patent cliffs & loss of exclusivity

Iron-Deficiency Treatments

Company

Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/vifor-pharma
Full AddressFlughofstrasse 61 P.O. Box 8152 Glattbrugg Switzerland
LinkedIn URLhttps://www.linkedin.com/company/vifor-pharma
Seedtable URLhttps://seedtable.com/companies/vifor-pharma
Twitter URLhttps://www.twitter.com/ViforPharma
Official Websitehttps://viforpharma.com
YouTube Channelhttps://www.youtube.com/channel/UC5tU1fqMdz4z-Fo3xHzQ4ow

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VELTASSAPATIROMER SORBITEX CALCIUMSmall mol.Oct 2033
  2. VELTASSAPATIROMER SORBITEX CALCIUMSmall mol.Oct 2033
  3. VELTASSAPATIROMER SORBITEX CALCIUMSmall mol.Oct 2033
  4. VELTASSAPATIROMER SORBITEX CALCIUMSmall mol.Oct 2033

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Vifor Pharma — patent cliffs & loss of exclusivity | CliffBio